3.75 mg tirzepatide Oral | Starts at $279/mo Microdosing Tirzepatide Chart: A Monthly
Description
The label starts at 2.5 mg weekly, long-duration obesity evidence starts at 5 mg, and registered human activity has been measured as low as 1 mg in an early diabetes study. Each number answers a different question
A comprehensive evaluation by a healthcare provider is crucial to weigh the potential benefits of these medications against the risks and ensure patient safety
Products available for direct purchase without medical oversight violate basic pharmaceutical safety principles
Here are some general guidelines to keep in mind: Take once daily, around the same time each day
Work with your healthcare provider to determine whether you have specific nutrient needs that warrant supplementation
Our goal is to support you in achieving safe, sustainable results while optimizing your overall health and well-being
